Lv3
250 积分 2021-09-06 加入
Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
3天前
已完结
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial
3天前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
3天前
已完结
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia
3天前
已完结
Shengbai oral solution for chemotherapy-induced neutropenia and symptom management in non-small cell lung cancer: A multicenter, randomized, open-label trial
5天前
已完结
Thiotepa and Busulfan Combined With Cyclophosphamide Conditioning Regimen Plus Maintenance Therapy Improved the Disease-Free Survival of Patients With Relapsed/Refractory Hematologic Malignancies After Undergoing Allogeneic Transplantation
5天前
已完结
Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms
5天前
已完结
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
12天前
已完结
Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial
13天前
已完结
皖公网安备34019202002308
